• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺微小乳头状癌主动监测的全球研究格局:一项文献计量分析

Global research landscape on active surveillance for papillary thyroid microcarcinoma: a bibliometric analysis.

作者信息

Kang Dong-Shu, Lin Yu-Hao, Tian Jian-Qing

机构信息

Department of Endocrinology, Xiamen Humanity Hospital, Xiamen, Fujian, China.

出版信息

Discov Oncol. 2025 Jun 7;16(1):1026. doi: 10.1007/s12672-025-02789-5.

DOI:10.1007/s12672-025-02789-5
PMID:40481973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12145405/
Abstract

BACKGROUND

It has been proven that the active surveillance (AS) is safe and feasible for low-risk papillary thyroid microcarcinomas (PTMC). There has been no bibliometric assessment of the scientific advancements in this field. We conducted this study to determine the characteristics and trends of published research on AS for PTMC.

METHODS

In this study, articles on AS for PTMC published between 2014 and 2024 were identified using the Web of Science Core Collection database. Bibliometric analysis and visualization were conducted using VOSviewer and CiteSpace.

RESULTS

277 publications from 39 countries were identified, demonstrating a growth trend between 2014 and 2024. The United States of America dominated with the highest number of published papers, followed closely by South Korea and Japan. The most significant journal was Thyroid, and the leading author was Akira Miyauchi. Kuma Hospital and Memorial Sloan Kettering Cancer Center emerged as leading institutions. Keyword analysis revealed that, alongside the title-related terms of this study, "management," "quality of life," "lymph node metastasis," "progression," and "association guidelines" formed the core keywords in this field.

CONCLUSION

Active surveillance for low-risk PTMC has been endorsed and recommended by researchers in numerous countries. This study identified the current most active frontiers in this field and focused on candidate population profiling, tumor progression evaluation, cost-effectiveness of the active surveillance (AS) approach, and quality of life assessment for patients. This paper summarizes the controversial issues and provides a reference direction for researchers seeking to explore novel approaches in this field.

摘要

背景

已证实主动监测(AS)对于低风险甲状腺微小乳头状癌(PTMC)是安全可行的。目前尚未对该领域的科学进展进行文献计量评估。我们开展本研究以确定关于PTMC主动监测的已发表研究的特征和趋势。

方法

在本研究中,使用科学网核心合集数据库识别2014年至2024年间发表的关于PTMC主动监测的文章。使用VOSviewer和CiteSpace进行文献计量分析和可视化。

结果

共识别出来自39个国家的277篇出版物,显示出2014年至2024年间的增长趋势。美国发表的论文数量最多,居主导地位,其次是韩国和日本。最重要的期刊是《甲状腺》,主要作者是宫内晃。熊本医院和纪念斯隆凯特琳癌症中心成为主要机构。关键词分析表明,除了与本研究标题相关的术语外,“管理”“生活质量”“淋巴结转移”“进展”和“关联指南”构成了该领域的核心关键词。

结论

对低风险PTMC的主动监测已得到许多国家研究人员的认可和推荐。本研究确定了该领域当前最活跃的前沿领域,并聚焦于候选人群特征分析、肿瘤进展评估、主动监测(AS)方法的成本效益以及患者生活质量评估。本文总结了有争议的问题,并为寻求探索该领域新方法的研究人员提供了参考方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/27616aa889e3/12672_2025_2789_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/7846ac8236ae/12672_2025_2789_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/a4e6ac0e1774/12672_2025_2789_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/6227588115ad/12672_2025_2789_Fig3a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/43715508ca4e/12672_2025_2789_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/0677eee637af/12672_2025_2789_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/13fe5ca0d2fb/12672_2025_2789_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/031e267f7500/12672_2025_2789_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/27616aa889e3/12672_2025_2789_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/7846ac8236ae/12672_2025_2789_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/a4e6ac0e1774/12672_2025_2789_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/6227588115ad/12672_2025_2789_Fig3a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/43715508ca4e/12672_2025_2789_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/0677eee637af/12672_2025_2789_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/13fe5ca0d2fb/12672_2025_2789_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/031e267f7500/12672_2025_2789_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf8/12145405/27616aa889e3/12672_2025_2789_Fig8_HTML.jpg

相似文献

1
Global research landscape on active surveillance for papillary thyroid microcarcinoma: a bibliometric analysis.甲状腺微小乳头状癌主动监测的全球研究格局:一项文献计量分析
Discov Oncol. 2025 Jun 7;16(1):1026. doi: 10.1007/s12672-025-02789-5.
2
Bibliometric insights in advances of papillary thyroid microcarcinoma: Research situation, hot points, and global trends.基于文献计量学的甲状腺微小乳头状癌研究进展分析:研究现状、热点及全球趋势
Front Endocrinol (Lausanne). 2022 Aug 8;13:949993. doi: 10.3389/fendo.2022.949993. eCollection 2022.
3
Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.全球甲状腺乳头癌治疗的研究现状和趋势:文献计量分析。
Front Endocrinol (Lausanne). 2023 Sep 19;14:1252389. doi: 10.3389/fendo.2023.1252389. eCollection 2023.
4
Mapping the lymph node metastasis landscape: A bibliometric Odyssey of papillary thyroid carcinoma publications (2012-2022).绘制淋巴结转移图谱:乳头状甲状腺癌出版物的文献计量学历程(2012 - 2022年)
Heliyon. 2024 May 16;10(10):e31398. doi: 10.1016/j.heliyon.2024.e31398. eCollection 2024 May 30.
5
Research hotspots and frontiers of machine learning in renal medicine: a bibliometric and visual analysis from 2013 to 2024.肾脏医学中机器学习的研究热点与前沿:2013年至2024年的文献计量学与可视化分析
Int Urol Nephrol. 2025 Mar;57(3):907-928. doi: 10.1007/s11255-024-04259-3. Epub 2024 Oct 30.
6
A dynamic study of the postoperative management of thyroid cancer from 2003 to 2022: a bibliometric analysis.2003年至2022年甲状腺癌术后管理的动态研究:文献计量分析
Gland Surg. 2023 Nov 24;12(11):1579-1593. doi: 10.21037/gs-23-218. Epub 2023 Nov 14.
7
Bibliometric analysis of laryngeal cancer treatment literature (2003-2023).喉癌治疗文献的文献计量分析(2003 - 2023年)
Heliyon. 2024 Dec 16;11(1):e40832. doi: 10.1016/j.heliyon.2024.e40832. eCollection 2025 Jan 15.
8
Characterization of global research hotspots and trends on ten-eleven translocation 2: visualization and bibliometric analysis.关于10-11易位蛋白2的全球研究热点与趋势的表征:可视化与文献计量分析
Am J Transl Res. 2022 Dec 15;14(12):8504-8522. eCollection 2022.
9
Evolutions in the management of non-small cell lung cancer: A bibliometric study from the 100 most impactful articles in the field.非小细胞肺癌管理的进展:基于该领域100篇最具影响力文章的文献计量学研究
Front Oncol. 2022 Aug 17;12:939838. doi: 10.3389/fonc.2022.939838. eCollection 2022.
10
Global hotspots and research trends of radiation-induced skin injury: a bibliometric analysis from 2004 to 2023.辐射诱导皮肤损伤的全球热点与研究趋势:2004年至2023年的文献计量分析
Front Oncol. 2024 Aug 26;14:1430802. doi: 10.3389/fonc.2024.1430802. eCollection 2024.

本文引用的文献

1
Single-cell transcriptomics analysis reveals that the tumor-infiltrating B cells determine the indolent fate of papillary thyroid carcinoma.单细胞转录组学分析表明,肿瘤浸润性B细胞决定了甲状腺乳头状癌的惰性命运。
J Exp Clin Cancer Res. 2025 Mar 11;44(1):91. doi: 10.1186/s13046-025-03341-7.
2
Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America.将低危甲状腺癌的主动监测纳入临床实践:拉丁美洲的合作建议。
Arch Endocrinol Metab. 2024 Jun 3;68:e230371. doi: 10.20945/2359-4292-2023-0371. eCollection 2024.
3
Active surveillance vs. surgery in low-risk papillary thyroid microcarcinoma patients and the risk of loss to follow-up.
低危型甲状腺微小乳头状癌患者主动监测与手术治疗及随访丢失风险
Cancer Med. 2024 Aug;13(16):e70123. doi: 10.1002/cam4.70123.
4
Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance.低风险乳头状甲状腺癌(mPTC)主动监测的分子特征分析
J Clin Endocrinol Metab. 2025 Feb 18;110(3):685-692. doi: 10.1210/clinem/dgae575.
5
Ultrasound Imaging in Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer.超声成像在小的、低风险的甲状腺乳头状癌主动监测中的应用。
Korean J Radiol. 2024 Aug;25(8):749-755. doi: 10.3348/kjr.2024.0148. Epub 2024 Jul 15.
6
Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma.基于低危型甲状腺乳头状癌主动监测中肿瘤倍增时间的肿瘤生长动力学。
Thyroid. 2024 Jul;34(7):846-855. doi: 10.1089/thy.2024.0054.
7
Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.主动监测是一种可行且安全的策略,适用于在甲状腺切除术后发现可疑颈部淋巴结的特定甲状腺乳头状癌患者。
Arch Endocrinol Metab. 2024 May 6;68:e230146. doi: 10.20945/2359-4292-2023-0146.
8
Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review.主动监测低危型甲状腺乳头状癌作为一种可接受的治疗选择,具有额外获益:全面系统综述。
Endocrinol Metab (Seoul). 2024 Feb;39(1):152-163. doi: 10.3803/EnM.2023.1794. Epub 2024 Jan 22.
9
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.主动监测低危甲状腺癌:当前实践指南综述。
Endocrinol Metab (Seoul). 2024 Feb;39(1):47-60. doi: 10.3803/EnM.2024.1937. Epub 2024 Feb 15.
10
Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.较大恶性和可疑甲状腺结节的非手术、主动监测。
J Clin Endocrinol Metab. 2024 Jul 12;109(8):1996-2002. doi: 10.1210/clinem/dgae082.